Skip to main content
Equibles
KROS logo

KROS · Keros Therapeutics, Inc. · Analyst Estimates

Track KROS — free

Use KROS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KROS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.17 -0.14 (-1.20%)
Russell 2000 member Rebalance outlook locked
Market Cap
$224.44M
Shares
19.83M

Analyst Estimates

Analyst consensus published through Keros Therapeutics, Inc.'s investor-relations sources. Coverage varies by company.

Values retain the original units, accounting basis and forecast-period labels.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1664710 CUSIP 492327101 13F (30d) 94 filings 94 filers Visit website Investor relations